Filtered By:
Specialty: Cardiology
Condition: Cardiomyopathy

This page shows you your search results in order of date. This is page number 18.

Order by Relevance | Date

Total 533 results found since Jan 2013.

Fabry disease in cardiology: Diagnosis and therapeutic approaches
Turk Kardiyol Dern Ars. 2020 Dec;48(Suppl 2):1-42. doi: 10.5543/tkda.2020.38262.ABSTRACTFabry disease is a rare, progressive, X-linked inherited storage disorder due to absent or deficient of lysosomal alfa galactosidase A activity. Deficient activity of alfa-galactosidase A results in progressive accumulation of globotriaosylceramide in a variety of tissues and organs including myocardium, kidney and nerve system. This disorder predominantly affects males; however, female heterozygotes may also be affected with a less severe clinical picture. Classic Fabry disease is usually diagnosed in early age of childhood because of ...
Source: Turk Kardiyoloji Dernegi arsivi - January 21, 2021 Category: Cardiology Authors: Y üksel Çavuşoğlu Ebru Özpelit Nur Arslan Mesut Demir G ökhan Kahveci H üseyin Onay Emir Özgür Barış Ökçün Oma ç Tufekcioglu Selcen Yakar T ülüce Gonca K ılıç Yıldırım Source Type: research

Atrial Fibrillation and Hypertrophic Cardiomyopathy: More Progress Needed
This article is protected by copyright. All rights reserved.
Source: Journal of Cardiovascular Electrophysiology - January 11, 2021 Category: Cardiology Authors: Jonathan Chrispin, Joseph E. Marine Tags: EDITORIAL ‐ INVITED Source Type: research

Modification of ventriculo –arterial coupling by spironolactone in nonischemic dilated cardiomyopathy
ConclusionsIn NIDCM, adding MRA to conventional anti ‐failure therapy markedly improved LV ejection fraction and reduced peripheral vascular resistance, due to both improved LV contractility and especially to enhanced V–A coupling, as Ea decreased to normal. Total circulatory performance was a sensitive indicator of both LV pump performance and th e arterial loading conditions.
Source: ESC Heart Failure - January 5, 2021 Category: Cardiology Authors: Mark A. Lawson, David E. Hansen, Deepak K. Gupta, Susan P. Bell, Douglas W. Adkisson, Ravinder R. Mallugari, Douglas B. Sawyer, Henry Ooi, Marvin W. Kronenberg Tags: Original Research Article Source Type: research

Cardiovascular Complications of Prostate Cancer Therapy
AbstractPurpose of reviewWith treatment advances, the most common cause of death in prostate cancer patients is cardiovascular disease. Discerning the contribution of prostate cancer treatment on cardiovascular complications versus the natural progression of cardiovascular disease remains an ongoing area of investigation. Evaluating the research and identifying opportunities for further investigation is critical for optimal care of this prostate cancer patient population.Recent findingsThe degree that hormone therapy contributes to cardiovascular morbidity and mortality remains uncertain with conflicting results from large...
Source: Current Treatment Options in Cardiovascular Medicine - November 12, 2020 Category: Cardiology Source Type: research

Peripartum cardiomyopathy: An uncommon cause of ischemic stroke.
Abstract A previously healthy 22-year-old woman with a history with a healthy pregnancy presented 12 weeks after an uneventful delivery with progressive dyspnea and edema. Initial blood workup was relevant for an elevated B-type natriuretic peptide in 1641 pg/mL (reference: 0-100). PMID: 33181805 [PubMed - as supplied by publisher]
Source: Archivos de Cardiologia de Mexico - November 12, 2020 Category: Cardiology Authors: Jiménez-Ruiz A, García-Grimshaw M, Ortega-Márquez J, Moreno-Guillen A, Flores-Silva FD, Cantú-Brito C Tags: Arch Cardiol Mex Source Type: research

Stroke risk stratification in hypertrophic cardiomyopathy.
Authors: Zhang J, Potpara T, Lip GY PMID: 33166651 [PubMed - as supplied by publisher]
Source: Hellenic Journal of Cardiology - November 11, 2020 Category: Cardiology Tags: Hellenic J Cardiol Source Type: research

540 Recurrent Stress Induced Cardiomyopathy Complicated by Acute Ischaemic Stroke
A 58 year old nurse presented with intermittent headache associated with vomiting for the preceding ten days. Neuroimaging including CT and MRI of the brain demonstrated recent infarction in the right middle cerebral artery (MCA) territory.
Source: Heart, Lung and Circulation - November 8, 2020 Category: Cardiology Authors: S. Brienesse, S. Adera Source Type: research

EvaLuation Using Cardiac Insertable Devices And TelephonE in Hypertrophic Cardiomyopathy (ELUCIDATE HCM): A prospective observational study on incidence of arrhythmias
ConclusionIn this first prospective study using an ICM, the arrhythmia burden in HCM patients yielded 30.0% AF and 23.3% NSVT.
Source: Journal of Cardiovascular Electrophysiology - November 4, 2020 Category: Cardiology Authors: Peter Magnusson, Stellan M örner Tags: ORIGINAL ‐ DEVICES Source Type: research

EvaLuation Using Cardiac Insertable Devices And TelephonE in Hypertrophic Cardiomyopathy (ELUCIDATE HCM): a prospective observational study on incidence of arrhythmias
ConclusionIn this first prospective study using an ICM, the arrhythmia burden in HCM patients yielded 30.0% AF and 23.3% NSVT.This article is protected by copyright. All rights reserved.
Source: Journal of Cardiovascular Electrophysiology - October 27, 2020 Category: Cardiology Authors: Peter Magnusson, Stellan M örner Tags: ORIGINAL ‐ DEVICES Source Type: research

Anticoagulation for Stroke Prevention in Patients With Hypertrophic Cardiomyopathy and Atrial Fibrillation: A Review
Atrial fibrillation is the most common arrhythmia in patients with hypertrophic cardiomyopathy with a prevalence and incidence of 23% and 3.1% respectively. The risk of thromboembolism is high in patients with hypertrophic cardiomyopathy regardless of the CHADS2VASC score. This review includes five observational studies that focused on prevention of thromboembolism in patients with hypertrophic cardiomyopathy and atrial fibrillation. These papers evaluated and compared outcomes between patients on either warfarin or direct oral anticoagulants.
Source: Heart Rhythm - October 2, 2020 Category: Cardiology Authors: M. Farhan Nasser, Sanjay Gandhi, Robert J. Siegel, Florian Rader Source Type: research

Caseous mitral valve calcification and concurrent hypertrophic obstructive cardiomyopathy: A rare cause of stroke
Publication date: October 2020Source: IJC Heart & Vasculature, Volume 30Author(s): Waqas Ullah, Donald Haas, Talal Almas, Aws- Al-Mukhtar, Asad Inayat
Source: IJC Heart and Vasculature - September 30, 2020 Category: Cardiology Source Type: research

Atrial fibrillation, anticoagulation management and risk of stroke in the Cardiomyopathy/Myocarditis registry of the EURObservational Research Programme of the European Society of Cardiology
ConclusionsThe study reveals a high prevalence and diverse distribution of AF in patients with cardiomyopathies, inadequate anticoagulation regimen, and high risk of stroke/TIA in this population.
Source: ESC Heart Failure - September 16, 2020 Category: Cardiology Authors: Katarzyna Mizia ‐Stec, Alida L.P. Caforio, Philippe Charron, Juan R. Gimeno, Perry Elliott, Juan Pablo Kaski, Aldo P. Maggioni, Luigi Tavazzi, Angelos G. Rigopoulos, Cecile Laroche, Attila Frigy, Elisabetta Zachara, Maria Luisa Pena‐Pena, Tags: Original Research Article Source Type: research

Mortality risk in dilated cardiomyopathy: the accuracy of heart failure prognostic models and dilated cardiomyopathy ‐tailored prognostic model
ConclusionsAn analysis of various HF prognostic models found them to be suboptimal for DCM patients. A self ‐developed DCM prognostic model showed improved performance over the nine other models studied. However, further validation of the prognostic model in different DCM populations is required.
Source: ESC Heart Failure - August 26, 2020 Category: Cardiology Authors: Ewa Dziewi ęcka, Matylda Gliniak, Mateusz Winiarczyk, Arman Karapetyan, Sylwia Wiśniowska‐Śmiałek, Aleksandra Karabinowska, Marcin Dziewięcki, Piotr Podolec, Paweł Rubiś Tags: Original Research Article Source Type: research

The hospitalizations in hypertrophic cardiomyopathy: “the dark side of the moon”.
Hypertrophic cardiomyopathy (HCM) is a myocardial disease characterized by left ventricular hypertrophy not solely explainable by abnormal loading condition [1,2]. Patients with HCM show a different clinical course, ranging from an asymptomatic status, with no adverse events and normal or extended longevity, to a symptomatic condition in which several disease complications can occur [3]. Among HCM patients which experience disease progression, 3 different pathways have been identified: refractory heart failure (HF), requiring surgical myectomy/alcohol ablation (obstructive HCM, OHCM) or heart transplant (non-obstructive HC...
Source: International Journal of Cardiology - August 14, 2020 Category: Cardiology Authors: Emanuele Monda, Giuseppe Limongelli Tags: Editorial Source Type: research

The hospitalizations in hypertrophic cardiomyopathy: “The dark side of the moon”
Hypertrophic cardiomyopathy (HCM) is a myocardial disease characterized by left ventricular hypertrophy not solely explainable by abnormal loading condition [1,2]. Patients with HCM show a different clinical course, ranging from an asymptomatic status, with no adverse events and normal or extended longevity, to a symptomatic condition in which several disease complications can occur [3]. Among HCM patients which experience disease progression, 3 different pathways have been identified: refractory heart failure (HF), requiring surgical myectomy/alcohol ablation (obstructive HCM, OHCM) or heart transplant (non-obstructive HC...
Source: International Journal of Cardiology - August 14, 2020 Category: Cardiology Authors: Emanuele Monda, Giuseppe Limongelli Tags: Editorial Source Type: research